INVENTIVA SA EUR0.01 revenue for the last year amounted to 17.48 M EUR, the most of which — 17.48 M EUR — came from its highest performing source at the moment, Oral Small Molecule Therapies, the year earlier bringing 12.18 M EUR. The greatest contribution to the revenue figure was made by Japan — last year it brought INVENTIVA SA EUR0.01 12.75 M EUR.